Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy?

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of March 31st. The results of that effort will be put on display in this article, as we share valuable insight into the smart money sentiment towards Edgewise Therapeutics, Inc. (NASDAQ:EWTX).

Is EWTX a good stock to buy? Money managers were buying. The number of bullish hedge fund bets improved by 16 recently. Edgewise Therapeutics, Inc. (NASDAQ:EWTX) was in 16 hedge funds’ portfolios at the end of March. Our calculations also showed that EWTX isn’t among the 30 most popular stocks among hedge funds (click for Q1 rankings).

In the eyes of most stock holders, hedge funds are viewed as slow, old financial tools of years past. While there are over 8000 funds trading today, Our researchers hone in on the masters of this group, around 850 funds. It is estimated that this group of investors preside over most of the hedge fund industry’s total asset base, and by paying attention to their highest performing picks, Insider Monkey has unsheathed numerous investment strategies that have historically defeated the market. Insider Monkey’s flagship short hedge fund strategy defeated the S&P 500 short ETFs by around 20 percentage points annually since its inception in March 2017. Also, our monthly newsletter’s portfolio of long stock picks returned 206.8% since March 2017 (through May 2021) and beat the S&P 500 Index by more than 115 percentage points. You can download a sample issue of this newsletter on our website .

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, pet market is growing at a 7% annual rate and is expected to reach $110 billion in 2021. So, we are checking out the 5 best stocks for animal lovers. We go through lists like the 15 best Jim Cramer stocks to identify the next Tesla that will deliver outsized returns. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. Keeping this in mind let’s analyze the key hedge fund action regarding Edgewise Therapeutics, Inc. (NASDAQ:EWTX).

Do Hedge Funds Think EWTX Is A Good Stock To Buy Now?

At the end of March, a total of 16 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 16 from the fourth quarter of 2020. By comparison, 0 hedge funds held shares or bullish call options in EWTX a year ago. So, let’s see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

Among these funds, OrbiMed Advisors held the most valuable stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX), which was worth $453.2 million at the end of the fourth quarter. On the second spot was Deerfield Management which amassed $127.8 million worth of shares. Viking Global, RA Capital Management, and Citadel Investment Group were also very fond of the stock, becoming one of the largest hedge fund holders of the company. In terms of the portfolio weights assigned to each position OrbiMed Advisors allocated the biggest weight to Edgewise Therapeutics, Inc. (NASDAQ:EWTX), around 4.24% of its 13F portfolio. Logos Capital is also relatively very bullish on the stock, earmarking 3.35 percent of its 13F equity portfolio to EWTX.

As industrywide interest jumped, specific money managers have jumped into Edgewise Therapeutics, Inc. (NASDAQ:EWTX) headfirst. OrbiMed Advisors, initiated the most valuable position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX). OrbiMed Advisors had $453.2 million invested in the company at the end of the quarter. James E. Flynn’s Deerfield Management also made a $127.8 million investment in the stock during the quarter. The other funds with new positions in the stock are Andreas Halvorsen’s Viking Global, Peter Kolchinsky’s RA Capital Management, and Ken Griffin’s Citadel Investment Group.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Edgewise Therapeutics, Inc. (NASDAQ:EWTX) but similarly valued. We will take a look at LendingClub Corp (NYSE:LC), Enterprise Financial Services Corp (NASDAQ:EFSC), Forterra, Inc. (NASDAQ:FRTA), Cardiovascular Systems Inc (NASDAQ:CSII), Schweitzer-Mauduit International, Inc. (NYSE:SWM), Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:VLRS), and Griffon Corporation (NYSE:GFF). This group of stocks’ market values are similar to EWTX’s market value.

View table here if you experience formatting issues.

As you can see these stocks had an average of 13.9 hedge funds with bullish positions and the average amount invested in these stocks was $145 million. That figure was $1052 million in EWTX’s case. LendingClub Corp (NYSE:LC) is the most popular stock in this table. On the other hand Schweitzer-Mauduit International, Inc. (NYSE:SWM) is the least popular one with only 7 bullish hedge fund positions. Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for EWTX is 70. Stocks with higher number of hedge fund positions relative to other stocks as well as relative to their historical range receive a higher sentiment score. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 5 most popular stocks among hedge funds returned 95.8% in 2019 and 2020, and outperformed the S&P 500 ETF (SPY) by 40 percentage points. These stocks gained 28.5% in 2021 through July 23rd and beat the market again by 10.1 percentage points. Unfortunately EWTX wasn’t nearly as popular as these 5 stocks and hedge funds that were betting on EWTX were disappointed as the stock returned -38.1% since the end of March (through 7/23) and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 5 most popular stocks among hedge funds as many of these stocks already outperformed the market since 2019.

Suggested Articles:

• 10 Fastest Growing Franchises in the US in 2020
• 20 Largest Milk Producing Countries in 2021
• 10 Best Used Car Stocks To Buy

Disclosure: None. This article was originally published at Insider Monkey.